Gene-editing therapies face safety challenges because even highly specific DNA-targeting systems can occasionally edit the wrong sequences, especially when treating many cells. To address this, researchers used AlphaFold to identify parts of gene-editing proteins linked to off-target activity.
They then modified those regions to reduce unintended edits. The work was published in Nature.
Comments